triiodothyronine has been researched along with Amyotrophic Lateral Sclerosis in 9 studies
Triiodothyronine: A T3 thyroid hormone normally synthesized and secreted by the thyroid gland in much smaller quantities than thyroxine (T4). Most T3 is derived from peripheral monodeiodination of T4 at the 5' position of the outer ring of the iodothyronine nucleus. The hormone finally delivered and used by the tissues is mainly T3.
3,3',5-triiodo-L-thyronine : An iodothyronine compound having iodo substituents at the 3-, 3'- and 5-positions. Although some is produced in the thyroid, most of the 3,3',5-triiodo-L-thyronine in the body is generated by mono-deiodination of L-thyroxine in the peripheral tissues. Its metabolic activity is about 3 to 5 times that of L-thyroxine. The sodium salt is used in the treatment of hypothyroidism.
Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)
Excerpt | Relevance | Reference |
---|---|---|
"Thyronine (T4), triiodothyronine (T3), and reverse-triiodothyronine (rT3) levels were evaluated in cerebrospinal fluid (CSF) and in serum of 12 patients with definite amyotrophic lateral sclerosis (ALS) by specific radioimmunoassays." | 3.67 | T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. ( Fuhrmann, H; Ködding, R; Malin, JP; von zur Mühlen, A, 1989) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (33.33) | 18.7374 |
1990's | 4 (44.44) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Zheng, Z | 1 |
Guo, X | 1 |
Huang, R | 1 |
Chen, X | 1 |
Shang, H | 1 |
Iłzecka, J | 1 |
Stelmasiak, Z | 1 |
Nobukuni, K | 1 |
Hayakawa, N | 1 |
Namba, R | 1 |
Ihara, Y | 1 |
Sato, K | 1 |
Takada, H | 1 |
Hayabara, T | 1 |
Kawahara, S | 1 |
Golovkin, VI | 1 |
Korovin, KF | 1 |
Iampol'skaia, LI | 1 |
Dobrov, SA | 1 |
Chiodini, PG | 2 |
Attanasio, R | 2 |
Liuzzi, A | 1 |
Cozzi, R | 1 |
Orlandi, P | 1 |
De Palo, C | 1 |
Dallabonzana, D | 1 |
Girotti, F | 2 |
Testa, D | 2 |
Malin, JP | 1 |
Ködding, R | 1 |
Fuhrmann, H | 1 |
von zur Mühlen, A | 1 |
Kaplan, MM | 1 |
Taft, JA | 1 |
Reichlin, S | 1 |
Munsat, TL | 1 |
Gueguen, B | 1 |
Puymirat, J | 1 |
Grouselle, D | 1 |
Piketty, ML | 1 |
Bleton, JP | 1 |
Bourdel, MC | 1 |
Rondot, P | 1 |
9 other studies available for triiodothyronine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
An exploratory study of the association between thyroid hormone and survival of amyotrophic lateral sclerosis.
Topics: Adult; Age of Onset; Aged; Amyotrophic Lateral Sclerosis; China; Female; Humans; Male; Middle Aged; | 2014 |
Thyroid function in patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Female; Humans; Male; Middle Aged; | 2003 |
The influence of long-term treatment with povidone-iodine on thyroid function.
Topics: Amyotrophic Lateral Sclerosis; Anti-Infective Agents, Local; Catheterization, Central Venous; Female | 1997 |
[Neuroendocrine aspects of the pathogenesis and treatment of disseminated sclerosis and lateral amyotrophic sclerosis].
Topics: Adult; Amyotrophic Lateral Sclerosis; Arginine Vasopressin; Diagnosis, Differential; Drug Therapy, C | 1990 |
Prolactin response to growth hormone-releasing hormone during chronic thyrotropin-releasing hormone infusion in the treatment of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Down-Regulation; Female; Growth Hormone; Growth Hormone-Releasing Hor | 1990 |
Amyotrophic lateral sclerosis: thyroid and prolactin hormone changes in thyrotropin-releasing hormone therapy.
Topics: Amyotrophic Lateral Sclerosis; Female; Growth Hormone-Releasing Hormone; Humans; Male; Middle Aged; | 1990 |
T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Humans; Male; Middle Aged; Thyronines; Triiodoth | 1989 |
Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Female; Humans; Long-Term Care; Male; Pituitary Function Tests; Prola | 1986 |
[Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
Topics: Acetylcholinesterase; Adult; Aged; Amyotrophic Lateral Sclerosis; Female; Follicle Stimulating Hormo | 1988 |